|
| Exchange Disseminated Time | Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 14, 2015, has:
1. Decided to conduct the Postal Ballot of the Company pursuant to Section 110 of the Companies Act, 2013 and rules prescribed thereunder for seeking shareholders approval for appointment of Mr. Ramesh Modi as an Independent Director of the Company with effect from March 31, 2015.
2. Approved and Finalized the Notice of Postal Ballot pursuant to Section 110 of the Companies Act, 2013 and rules prescribed thereunder for the above mentioned matter.
3. Finalized the appointment of Mr. Deep Shukla, Practicing Company Secretary as the Scrutinizer to oversee the e-voting process in a fair and transparent manner and to submit the Report regarding declaration of the results of the said Postal Ballot
4. Authorized Mr. Mukund Mehta, Managing Director of the Company to oversee the entire Postal Ballot process as aforesaid.
5. Approved the delisting of the Company's securities from National Stock Exchange of India Limited, but will continue to be listed on Bombay Stock Exchange Limited, being the Regional Stock Exchange of the Company.
6. Other Matters:
Approved the investment upto USD 200,000 (approx. INR 1,25,00,000/-) in KILITCH ESTRO BIOTECH PLC, located at Addis Ababa, Ethiopia. |
|
|